EDGAR Filing Documents for 0001144204-11-018823

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-11-018823

Filing Date

2011-03-31

Accepted

2011-03-31 13:15:28

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	v216719_10k.htm	10-K	2108863
2	GRAPHIC	footer.jpg	GRAPHIC	3354
3	GRAPHIC	logo.jpg	GRAPHIC	2563
4	EX-10.37	v216719_ex10-37.htm	EX-10.37	62144
5	EX-10.38	v216719_ex10-38.htm	EX-10.38	73510
6	EX-10.39	v216719_ex10-39.htm	EX-10.39	58874
7	EX-10.40	v216719_ex10-40.htm	EX-10.40	74210
8	EX-23	v216719_ex23.htm	EX-23	4466
9	EX-31.1	v216719_ex31-1.htm	EX-31.1	11873
10	EX-31.2	v216719_ex31-2.htm	EX-31.2	11849
11	EX-32.1	v216719_ex32-1.htm	EX-32.1	6427
12	EX-32.2	v216719_ex32-2.htm	EX-32.2	6486
	Complete submission text file	0001144204-11-018823.txt		2428295

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019

Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553

BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-61610 | Film No.: 11724968
SIC: 2836 Biological Products, (No Diagnostic Substances)